AMD Research
Baseline clinical measures and early response predict success in verteporfin photodynamic therapy for neovascular age-related macular degeneration
Friday, January 15th, 2010Extract not available.
Discovery Points Toward Anti-Inflammation Treatment For Blinding Disease (Medical News Today)
Friday, January 15th, 2010The discovery of an inflammatory mediator key to the blinding effects of diabetic retinopathy is pointing toward a potential new treatment, Medical College of Georgia researchers said. Interleukin-6, known to contribute to the debilitating joint inflammation of rheumatoid arthritis, also helps ignite inflammation of the retina, a first step in a disease that is the leading cause of blindness is …
Acucela initiates Phase II age-related macular degeneration trial
Friday, January 15th, 2010its Envision Clarity Trial, a Phase II clinical trial of ACU-4429, an investigational oral treatment for dry age-related macular degeneration, or dry AMD. This Phase II trial is a randomized, double-masked, placebo-controlled study of three planned
Province of British Columbia: B.C. Researcher Developing Vision-Saving Gene Therapy
Thursday, December 3rd, 2009Another breakthrough treatment for macular degeneration ‘ the leading cause of vision loss in Canada ‘ is being developed in B.C. by a top genetic ophthalmologist who came here from the U.K. because of the
Macular Health eye vitamin supplement improves visual acuity (News-Medical-Net)
Thursday, December 3rd, 2009Adults are more likely to lose their vision than be diagnosed with cancer. For adults 65 and over, the odds of losing vision are one in three, whereas the odds of a man developing prostate cancer are one in six and odds of a woman developing breast cancer are one in nine. Vision loss threatens the overall health of aging adults by increasing the risk of injuries, depression and inability to …
Can Heart Disease Treatments Combat AMD?
Wednesday, December 2nd, 2009Can treatments that reduce risks for cardiovascular disease (CVD) also help combat age-related macular degeneration (AMD) , an eye disease that affects millions of Americans? CVD and AMD share some risk factors�such as smoking, high blood pressure,
Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer
Wednesday, December 2nd, 2009of injuries, depression and inability to complete daily tasks. Vision loss in adults is often attributed to age-related macular degeneration (AMD), a breakdown of the macula that destroys sharp, central vision. Damage to the macula causes blurriness and
NeoVista epimacular brachytherapy system in UK clinical trial
Wednesday, December 2nd, 2009NeoVista Inc.’s new epimacular brachytherapy system (Vidion Anti-Neovascular Surgical System) for the treatment of age-related macular degeneration is now available in the United Kingdom
Egg Yolks May Reduce Risk Of Macular Degeneration
Monday, November 30th, 2009Regular egg yolk consumption may reduce the risk of dry, age-related macular degeneration according to a report in the November issue of the American Journal of Clinical Nutrition.(1) Eating egg yolks – which contain the nutrients lutein and zeaxanthin
AMD Alliance International organizes video contest to raise awareness
Friday, October 2nd, 2009AMD Alliance International is hosting a video contest to raise awareness for age-related macular degeneration (AMD). Individuals are invited to create and submit videos of no longer than 3 minutes that will communicate in the most creative and
